Original Contributions |
From the Centre for Genetics of Cardiovascular Disorders, Department of Medicine, UCL Medical School, The Rayne Institute, London, England (S.E.H., P.J.T.); INSERM U258, Paris, France (V.N., L.T.); and the Facultat de Medicina, Universitat Rovira i Virgili, Reus, Spain (J.M.).
AbstractThe
H-allele of the intron 8
HindIII polymorphism in the lipoprotein lipase
(LPL) gene has been associated with a lower risk of myocardial
infarction (MI) and plasma levels of triglycerides (TG). To
test whether the HindIII site was in linkage
disequilibrium with the functional variant LPL Serine447Stop (S447X),
subjects from the European Atherosclerosis Research
Study (EARS I) were genotyped for both polymorphic sites.
This study included 515 offspring of fathers with a premature (<55
years old) MI, who were designated cases, and 930 age- and sex-matched
control subjects from five different regions of Europe. Linkage
disequilibrium between the two sites was very strong (>.99), with only
three of the four possible haplotypes identified:
H+S447, H-S447, and
H-X447. The frequency of the
H-X447 but not of the H-S447
haplotype was significantly lower in cases than in control subjects
(.090 versus .117, P<.01) suggesting a protective
effect for MI, with this difference being consistent in all
five regions of Europe. Compared with individuals homozygous for the
H+S447 haplotype, the odds ratio of having a
paternal history of premature MI for H-X447
heterozygotes (
20% of the population) was 0.71 (95% confidence
interval, 0.55 to 0.92). In addition, there was an increase of the
H-X447 haplotype frequency from north to south in
control subjects (0.119 in Finland to 0.143 in the Mediterranean
region, P<.01). Compared with the
H+S447 haplotype, the H-X447
haplotype was associated with significantly lower concentrations of
plasma TGs (5.4% lower, P=.01), with this effect
being consistent over the regions of Europe. There was no
significant evidence for a heterogeneity of effect
between males and females or between cases and control subjects,
although the effect on TG levels appeared to be the greatest in male
cases (11% lower, P=.05). In a second study (EARS
II), of 332 cases and 342 control subjects, postprandial clearance of
TGs after a standard fat meal was examined. The
H-X447 haplotype was associated with significantly
lower postprandial triglyceride levels than was the
H+S447 haplotype (9.4% smaller area under the
curve, P<.05). Thus, the effects on MI risk and
plasma lipids associated with the H allele
appeared to be mainly mediated by the X447 mutation, and although the
lowering effects associated with the H-X447
haplotype on fasting and postprandial TGs are not large, they are
consistent with the lowering effect observed on MI risk
throughout Europe.
Key Words: lipoprotein lipase HindIII polymorphism Ser447X offspring
This article has been cited by other articles:
![]() |
R. Frikke-Schmidt, B. G. Nordestgaard, M. C. A. Stene, A. A. Sethi, A. T. Remaley, P. Schnohr, P. Grande, and A. Tybjaerg-Hansen Association of Loss-of-Function Mutations in the ABCA1 Gene With High-Density Lipoprotein Cholesterol Levels and Risk of Ischemic Heart Disease JAMA, June 4, 2008; 299(21): 2524 - 2532. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Valdez, K. J. Greenlund, M. J. Khoury, and P. W. Yoon Is Family History a Useful Tool for Detecting Children at Risk for Diabetes and Cardiovascular Diseases? A Public Health Perspective Pediatrics, September 1, 2007; 120(SUPPLEMENT_2): S78 - S86. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ak, S. Isbir, A. Tekeli, A. Ergen, N. Atalan, S. Dogan, A. Civelek, and S. Arsan Presence of lipoprotein lipase S447X stop codon affects the magnitude of interleukin 8 release after cardiac surgery with cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., August 1, 2007; 134(2): 477 - 483. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. N. Thu, T. T. T. Mai, R. Ohmori, M. Kuroki, N. V. Chuyen, N. T. K. Hung, M. Kawakami, and K. Kondo Plasma Triglyceride and HDL-Cholesterol Concentrations in Vietnamese Girls Are Affected by Lipoprotein Lipase, but Not Apolipoprotein CIII Polymorphism J. Nutr., June 1, 2006; 136(6): 1488 - 1492. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Rip, M. C. Nierman, C. J. Ross, J. W. Jukema, M. R. Hayden, J. J.P. Kastelein, E. S.G. Stroes, and J. A. Kuivenhoven Lipoprotein Lipase S447X: A Naturally Occurring Gain-of-Function Mutation Arterioscler Thromb Vasc Biol, June 1, 2006; 26(6): 1236 - 1245. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Hegele, C. J.D. Ross, J. Twisk, J. A. Kuivenhoven, J. Rip, J. J. Kastelein, and M. R. Hayden Gene therapy with lipoprotein lipase variant S447X. Arterioscler Thromb Vasc Biol, March 1, 2006; 26(3): e25 - e25. [Full Text] [PDF] |
||||
![]() |
J. Rip, M. C. Nierman, N. J. Wareham, R. Luben, S. A. Bingham, N. E. Day, J. N.I. van Miert, B. A. Hutten, J. J.P. Kastelein, J. A. Kuivenhoven, et al. Serum Lipoprotein Lipase Concentration and Risk for Future Coronary Artery Disease: The EPIC-Norfolk Prospective Population Study Arterioscler Thromb Vasc Biol, March 1, 2006; 26(3): 637 - 642. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Monraats, J. S. Rana, M. C. Nierman, N. M.M. Pires, A. H. Zwinderman, J. J.P. Kastelein, J. A. Kuivenhoven, M. P.M. de Maat, S. Z.H. Rittersma, A. Schepers, et al. Lipoprotein Lipase Gene Polymorphisms and the Risk of Target Vessel Revascularization After Percutaneous Coronary Intervention J. Am. Coll. Cardiol., September 20, 2005; 46(6): 1093 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Goodarzi, H. Wong, M. J. Quinones, K. D. Taylor, X. Guo, L. W. Castellani, H. J. Antoine, H. Yang, W. A. Hsueh, and J. I. Rotter The 3' Untranslated Region of the Lipoprotein Lipase Gene: Haplotype Structure and Association with Post-Heparin Plasma Lipase Activity J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4816 - 4823. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yang, E. Ruiz-Narvaez, T. Niu, X. Xu, and H. Campos Genetic variants of the lipoprotein lipase gene and myocardial infarction in the Central Valley of Costa Rica J. Lipid Res., November 1, 2004; 45(11): 2106 - 2109. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Brousseau, A. L. Goldkamp, D. Collins, S. Demissie, A. C. Connolly, L. A. Cupples, J. M. Ordovas, H. E. Bloomfield, S. J. Robins, and E. J. Schaefer Polymorphisms in the gene encoding lipoprotein lipase in men with low HDL-C and coronary heart disease: The Veterans Affairs HDL Intervention Trial J. Lipid Res., October 1, 2004; 45(10): 1885 - 1891. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lopez-Miranda, G. Cruz, P. Gomez, C. MarIn, E. Paz, P. Perez-MartInez, F. J. Fuentes, J. M. Ordovas, and F. Perez-Jimenez The Influence of Lipoprotein Lipase Gene Variation on Postprandial Lipoprotein Metabolism J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4721 - 4728. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lee, C. S. Tan, K. S. Chia, C. E. Tan, S. K. Chew, J. M. Ordovas, and E. S. Tai The lipoprotein lipase S447X polymorphism and plasma lipids: interactions with APOE polymorphisms, smoking, and alcohol consumption J. Lipid Res., June 1, 2004; 45(6): 1132 - 1139. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Goodarzi, X. Guo, K. D. Taylor, M. J. Quinones, M. F. Saad, H. Yang, W. A. Hsueh, and J. I. Rotter Lipoprotein Lipase Is a Gene for Insulin Resistance in Mexican Americans Diabetes, January 1, 2004; 53(1): 214 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Spence, M. R. Ban, and R. A. Hegele Lipoprotein Lipase (LPL) Gene Variation and Progression of Carotid Artery Plaque Stroke, May 1, 2003; 34(5): 1176 - 1180. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Merkel, R. H. Eckel, and I. J. Goldberg Lipoprotein lipase: genetics, lipid uptake, and regulation J. Lipid Res., December 1, 2002; 43(12): 1997 - 2006. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cuomo, P. Guarini, G. Gaeta, M. de Michele, F. Boeri, J. Dorn, M.G. Bond, and M. Trevisan Increased carotid intima-media thickness in children-adolescents, and young adults with a parental history of premature myocardial infarction Eur. Heart J., September 1, 2002; 23(17): 1345 - 1350. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Corella, M. Guillen, C. Saiz, O. Portoles, A. Sabater, J. Folch, and J. M. Ordovas Associations of LPL and APOC3 gene polymorphisms on plasma lipids in a Mediterranean population: interaction with tobacco smoking and the APOE locus J. Lipid Res., March 1, 2002; 43(3): 416 - 427. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Garenc, L. Perusse, J. Bergeron, J. Gagnon, Y. C. Chagnon, I. B. Borecki, A. S. Leon, J. S. Skinner, J. H. Wilmore, D. C. Rao, et al. Evidence of LPL gene-exercise interaction for body fat and LPL activity: the HERITAGE Family Study J Appl Physiol, September 1, 2001; 91(3): 1334 - 1340. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Talmud, L. Berglund, E. M. Hawe, D. M. Waterworth, C. R. Isasi, R. E. Deckelbaum, T. Starc, H. N. Ginsberg, S. E. Humphries, and S. Shea Age-Related Effects of Genetic Variation on Lipid Levels: The Columbia University BioMarkers Study Pediatrics, September 1, 2001; 108(3): e50 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R Holmer, C. Hengstenberg, B. Mayer, A. Doring, H. Lowel, S. Engel, H.-W. Hense, M. Wolf, G. Klein, G. A.J Riegger, et al. Lipoprotein lipase gene polymorphism, cholesterol subfractions and myocardial infarction in large samples of the general population Cardiovasc Res, September 1, 2000; 47(4): 806 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Friedlander, P. J. Talmud, K. L. Edwards, S. E. Humphries, and M. A. Austin Sib-pair linkage analysis of longitudinal changes in lipoprotein risk factors and lipase genes in women twins J. Lipid Res., August 1, 2000; 41(8): 1302 - 1309. [Abstract] [Full Text] |
||||
![]() |
D. M. Waterworth, J. A. Hubacek, J. Pitha, J. Kovar, R. Poledne, S. E. Humphries, and P. J. Talmud Plasma levels of remnant particles are determined in part by variation in the APOC3 gene insulin response element and the APOCI;-APOE cluster J. Lipid Res., July 1, 2000; 41(7): 1103 - 1109. [Abstract] [Full Text] |
||||
![]() |
S. M. Clee, N. Bissada, F. Miao, L. Miao, A. D. Marais, H. E. Henderson, P. Steures, J. McManus, B. McManus, R. C. LeBoeuf, et al. Plasma and vessel wall lipoprotein lipase have different roles in atherosclerosis J. Lipid Res., April 1, 2000; 41(4): 521 - 531. [Abstract] [Full Text] |
||||
![]() |
M. Margaglione, G. Cappucci, D. Colaizzo, G. Vecchione, E. Grandone, and G. Di Minno C-Reactive Protein in Offspring Is Associated With the Occurrence of Myocardial Infarction in First-Degree Relatives Arterioscler Thromb Vasc Biol, January 1, 2000; 20(1): 198 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Larson, M. M. Hoffmann, J. M. Ordovas, E. J. Schaefer, W. Marz, and J. Kreuzer The Lipoprotein Lipase HindIII Polymorphism: Association with Total Cholesterol and LDL-Cholesterol, but not with HDL and Triglycerides in 342 Females Clin. Chem., July 1, 1999; 45(7): 963 - 968. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |